Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 10-K Report Annual Report
  2. NT 10-K Other NT 10-K
  3. CT ORDER Other Confidential Order
  4. 8-K Event Results of operations
  5. 4 Grant or award SVP, Chief Development Officer acquired 30,000 shares (grant or award)
  6. 4 Grant or award SVP, Chief Medical Officer acquired 80,000 shares (grant or award)
  7. 4 Grant or award SVP, Chief Business Officer acquired 65,000 shares (grant or award)
  8. 4 Grant or award SVP, CLO & Secretary acquired 65,000 shares (grant or award)
  9. 4 Grant or award SVP, CFO & Treasurer acquired 65,000 shares (grant or award)
  10. 4 Grant or award CEO and President acquired 239,500 shares (grant or award)
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. SC 13D/A Stake Beneficial Ownership Report
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 8-K Event Regulation FD disclosure · Other events
  19. SC 13D/A Stake Beneficial Ownership Report
  20. 8-K/A Event Executive or director change

Page 26 of 45 · 886 filings